Insider Trading Activity For Bio-Techne Corp (NASDAQ:TECH)
Roger C Lucas , Director of Bio-Techne Corp (NASDAQ:TECH) reportedly Sold 100 shares of the company’s stock at an average price of 114.3 for a total transaction amount of $11,430.00 SEC Form
Insider Trading History For Bio-Techne Corp (NASDAQ:TECH)
Analyst Ratings For Bio-Techne Corp (NASDAQ:TECH)
These are 2 Hold Ratings, 4 Buy Ratings .
The current consensus rating for Bio-Techne Corp (NASDAQ:TECH) is Buy (Score: 2.67) with a consensus target price of $123.75 , a potential (5.35% upside)
Analyst Ratings History For Bio-Techne Corp (NASDAQ:TECH)
- On 10/29/2015 Stephens Downgraded rating Overweight to Equal Weight
- On 11/2/2015 Craig Hallum Lower Price Target of rating Buy with a price target of $125.00 to $110.00
- On 8/18/2016 Robert W. Baird Boost Price Target of rating Outperform with a price target of $115.00 to $116.00
- On 11/10/2016 Leerink Swann Initiated Coverage of rating Outperform with a price target of $122.00
- On 3/27/2017 Janney Montgomery Scott Downgraded rating Buy to Neutral
- On 5/3/2017 Citigroup Inc. Reiterated Rating Buy with a price target of $115.00 to $125.00
- On 7/13/2017 Wells Fargo & Company Initiated Coverage of rating Market Perform to Market Perform
Dividend Information For Bio-Techne Corp (NASDAQ:TECH)
Bio-Techne Corp (NASDAQ:TECH) pays an annual dividend of Community Ranking: with a yield of Community Ranking:
Dividend History For Bio-Techne Corp (NASDAQ:TECH)
Recent Trading Activity for Bio-Techne Corp (NASDAQ:TECH)
Shares of Bio-Techne Corp closed the previous trading session at 117.47 down -0.07 -0.06% with 100,695 shares trading hands.